Group 1 - The core viewpoint of the article highlights the inauguration of China's first nuclear medical demonstration base at the Suzhou University Affiliated Second Hospital, which integrates nuclear technology for precise diagnosis and treatment, clinical trials, medical innovation, and training [1] - The nuclear medical industry in China is expected to experience accelerated growth due to policy benefits and technological breakthroughs, particularly in the areas of radionuclide preparation, radiopharmaceutical development, and nuclear medical equipment [1] - The Chinese nuclear medical market is projected to maintain rapid growth from 2025 to 2030, with an expected annual output value reaching approximately 600 billion yuan by the end of the 14th Five-Year Plan [1] Group 2 - Companies such as Jingye Intelligent and CGN Technology are mentioned in relation to the nuclear medical sector [2]

Core Viewpoint - China General Nuclear Power Group (CGN) is focusing on expanding cooperation in renewable energy, hydrogen energy, and nuclear technology applications with Inner Mongolia, aiming for mutual benefits and project implementation [1] Group 1: Cooperation Areas - CGN and Inner Mongolia are discussing deepening cooperation in renewable energy, hydrogen energy, and nuclear technology [1] - The parties aim to explore and launch several cooperative projects in nuclear energy, energy storage, and green hydrogen [1] Group 2: Investment and Development - CGN emphasizes its commitment to investment and development in Inner Mongolia [1] - The company plans to leverage its advantages in technology, management, and capital to enhance practical cooperation in various sectors [1] Group 3: Project Implementation - Future projects will focus on power transmission channels, large base development, desertification control, hydrogen pipeline construction, and nuclear medical equipment applications [1] - CGN aims to promote the implementation of high-quality projects in Inner Mongolia [1]